Response to comment on "Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy." Graefes Arch Clin Exp Ophthalmol. 2021 Jul 3. doi: 10.1007/s00417-021-05285-y.

MLA

Midena, Edoardo, et al. “Response to Comment on ‘Intraocular Fluid Biomarkers (Liquid Biopsy) in Human Diabetic Retinopathy.’ Graefes Arch Clin Exp Ophthalmol. 2021 Jul 3. Doi: 10.1007/S00417-021-05285-Y.” Graefe’s Archive of Clinical & Experimental Ophthalmology, vol. 260, no. 3, Mar. 2022, pp. 1041–42. EBSCOhost, https://doi.org/10.1007/s00417-021-05463-y.

APA

Midena, E., Frizziero, L., Midena, G., & Pilotto, E. (2022). Response to comment on “Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy.” Graefes Arch Clin Exp Ophthalmol. 2021 Jul 3. doi: 10.1007/s00417-021-05285-y. Graefe’s Archive of Clinical & Experimental Ophthalmology, 260(3), 1041–1042. https://doi.org/10.1007/s00417-021-05463-y

Chicago

Midena, Edoardo, Luisa Frizziero, Giulia Midena, and Elisabetta Pilotto. 2022. “Response to Comment on ‘Intraocular Fluid Biomarkers (Liquid Biopsy) in Human Diabetic Retinopathy.’ Graefes Arch Clin Exp Ophthalmol. 2021 Jul 3. Doi: 10.1007/S00417-021-05285-Y.” Graefe’s Archive of Clinical & Experimental Ophthalmology 260 (3): 1041–42. doi:10.1007/s00417-021-05463-y.